Fact CheckerSign in

NCT06017245Completed

The Bone-Myoregulation Reflex and Development of Sarcopenia in Osteoporosis

Could the Bone-Myoregulation Reflex Explain the Development of Sarcopenia in Postmenopausal and Senile Osteoporosis?

Source: ClinicalTrials.gov · Last updated 17 Jan 2024

Brief summary (registry, in English)

Bone and skeletal muscle are in a single unit that interacts with each other structurally and functionally. The aim of this study is to determine the contribution of bone myoregulation reflex as a neuronal crosstalk mechanism on the development of sarcopenia in postmenopausal and senile osteoporosis

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
24 Aug 2023
Start date
29 Aug 2023
Primary completion date
20 Dec 2023
Lead sponsor
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Diseases
Osteoporosis
NCT number
NCT06017245

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 29 Aug 2023 to the primary completion date, 20 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Those with polyneuropathy, central nervous system disease clinic/history
  • Myopathies (steroid, vitamin D deficiency, primary muscle diseases, etc.)
  • History of fracture in lower extremity, joint prosthesis

Other

  • Osteopenic cases
  • Possible sarcopenia (according to EWGSOP2 criteria)
  • Vertigo
  • Kidney stone
  • Panic attack story
  • Secondary osteoporosis
  • Cases with lesions on the soleus skin
  • Lower extremity active/acute thrombophlebitis

Who the study is looking for

  • For healthy young adults control Healthy volunteers aged 20-45 years
  • For postmenopausal osteoporosis Hip DXA T-score (neck or total hip) \< -2.5
  • For the Senile osteoporosis Over 65 years Male Hip DXA T-score (neck or total hip) \< -2.5 Female

Age in the registry: 20 years to 85 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ilhan Karacan
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.